Prescribing Hope: Transgender Medicine with Dr. Luke Allen | S04E04

🔊 Episode Description

In this episode, we sit down with licensed psychologist Dr. Luke R. Allen to explore groundbreaking research showing that access to gender affirming medical care — including hormone therapy — is associated with clinically meaningful reductions in suicidal ideation among transgender and gender diverse adolescents and young adults. Dr. Allen walks us through his study’s findings, discusses the implications for clinical practice, and shares insight on what this evidence means for providers who want to deliver affirming, life-saving care. 

🧠 About Dr. Luke R. Allen, PhD

Dr. Luke R. Allen (he/him) is a licensed clinical psychologist with extensive experience in research, clinical practice, and advocacy related to transgender and gender diverse health. He provides telehealth services across multiple states and specializes in supporting transgender and nonbinary youth, young adults, and their families with mental health, gender identity, and life affirming care. He is a Certified World Professional Association for Transgender Health (WPATH) Standards of Care Version 8 Member and Mentor and brings decades of training, scholarship, and clinical experience to both therapeutic work and scientific inquiry. (Luke R. Allen, PhD)

Dr. Allen’s approach emphasizes autonomy, dignity, and collaborative care — helping clients pursue meaningful lives on their own terms. His work bridges evidence, ethics, and community needs, with scholarly contributions that help shape our understanding of best practices in gender-affirming treatment. (Luke R. Allen, PhD)

Read more about Dr. Allen: https://lukeallenphd.com/about-me (Luke R. Allen, PhD)

📚 Study Summary: Changes in Suicidality Among Transgender Adolescents Following Hormone Therapy: An Extended Study

Published in The Journal of Pediatrics, this study tracked 432 transgender and gender-diverse adolescents and young adults who began hormone therapy and completed standardized suicide screening measures both before and after treatment. Over an average of nearly two years of follow-up, the researchers observed significant declines in suicidal ideation and related behavior following initiation of hormone therapy — a finding consistent across age groups and assigned sex at birth. These results extend earlier smaller studies and provide robust clinical evidence that timely access to gender affirming care can play a protective role in mental health outcomes for trans youth. (ScienceDirect)

📄 Read the study here:
https://www.jpeds.com/article/S0022-3476(25)00424-X/abstract (jpeds.com)